Metoclopramide Orion

Metoclopramide, the active ingredient in Metoclopramide Orion, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It is employed to relieve nausea and vomiting, manage postoperative nausea, and treat gastroparesis in adult patients, improving gastric emptying and lower esophageal sphincter tone.

GNH USA supplies Metoclopramide Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets across Europe, Asia, Africa and the Americas, and ensuring consistent quality through stringent quality‑assurance processes.

Metoclopramide acts on dopaminergic pathways to control nausea, vomiting and gastric motility.

Nausea and vomiting: reduces the frequency and severity of episodes by antagonizing central dopamine receptors involved in the emetic reflex. Gastroparesis: enhances gastric emptying and improves lower esophageal sphincter tone, thereby alleviating symptoms of delayed stomach emptying such as early satiety and bloating. Postoperative nausea and vomiting: prevents and treats nausea and vomiting that occur after surgical procedures, supporting patient recovery and comfort.

Metoclopramide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness - Fatigue - Restlessness or agitation - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., acute dystonia, akathisia) - Tardive dyskinesia with long‑term use - Neuroleptic malignant syndrome - Depression or suicidal thoughts

When prescribing Metoclopramide Orion, clinicians should consider several safety measures.

Assess renal and hepatic function before initiating therapy: adjust use in impairment. Monitor for extrapyramidal symptoms: discontinue if severe. Avoid in patients with known seizure disorders: risk of lowering seizure threshold. Use with caution in the elderly: increased sensitivity to CNS effects. Contraindicated in patients with known hypersensitivity to metoclopramide or other dopamine antagonists: discontinue immediately. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Metoclopramide Orion can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol, chlorpromazine): additive dopamine blockade may increase side effects. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - CNS depressants (e.g., benzodiazepines, opioids): enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Opioid analgesics: may potentiate nausea or sedation. - Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants: possible increased risk of serotonin syndrome. - Anticholinergic agents: may reduce pro‑kinetic efficacy. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may increase metoclopramide plasma levels.